How moderate wine drinking affects healthy aging through post-meal extracellular vesicles
Official title: Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles
Run by University of Seville · NCT07361887 · Data updated 2026-11-12
This test will see if a single serving of red or white wine changes circulating extracellular vesicles in healthy adults aged 35–65.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 36 Years |
| Sex | All |
| Enrollment | 8 (estimated) |
| Sponsor | University of Seville Academic / other |
| Locations | 1 site (Seville, Sevilla) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | December 1, 2025 |
| Study ends | March 31, 2027 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07361887 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy men and women aged 35–65 with BMI 18.5–29.9, non-smokers or ex-smokers for ≥12 months, moderate alcohol consumers, normal fasting glucose and lipids, and willing to follow pre-visit restrictions.
✕Probably not a fit
People with existing cardiovascular, metabolic, hepatic, renal, thyroid, or inflammatory diseases, those taking medications that alter metabolism, pregnant or breastfeeding individuals, smokers, or those outside the age/BMI ranges are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy adult participants will consume a single serving of red wine, white wine, or water while blood samples are taken before and after consumption to capture postprandial changes. Researchers will profile the EVs' lipidome and proteome and analyze their cargo and concentration. Functional assays will test how these EVs interact with vascular, immune, and brain-related cells, including potential effects on blood-brain barrier and microglia-relevant pathways. The goal is to link acute wine-induced EV changes to mechanisms relevant for cardiovascular and brain health.
Why it matters
Potential benefit: If successful, the results could clarify a biological mechanism by which moderate wine intake influences cardiovascular and brain health and guide dietary recommendations or EV-based therapies.
How similar studies have gone: While epidemiologic and mechanistic work supports moderate wine or polyphenol benefits for cardiovascular risk, using postprandial extracellular vesicle profiling to explain those effects is novel and largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Healthy adult men and women aged 35 to 65 years. * Body Mass Index (BMI) between 18.5 and 29.9 kg/m². * Non-smokers or ex-smokers for at least 12 months. * Moderate alcohol consumers, defined as ≤2 units/day for men and ≤1 unit/day for women. * Normal fasting glucose and lipid profile at screening. * Willing and able to refrain from alcohol, polyphenol-rich foods, and intense exercise for 48 hours before each study visit. * Able to understand the study procedures and provide written informed consent. Exclusion Criteria * History or clinical evidence of cardiovascular, hepatic, renal, thyroid, gastrointestinal, or metabolic diseases (including diabetes, dyslipidemia, or hypertension). * Use of medications or supplements known to affect glucose, lipid, or inflammatory metabolism (e.g., statins, corticosteroids, anti-inflammatory drugs). * Pregnancy or breastfeeding. * Recent blood donation (within the last 3 months) or planned blood donation during the study period. * Major weight change (\>5% of body weight) within the last 3 months. * Participation in another clinical or biomedical study within the previous 3 months. * Known allergy or intolerance to wine, alcohol, or its components (e.g., sulfites). * History of alcohol abuse or inability to abstain from alcohol outside the study context. * Reluctance to receive information about incidental health findings arising from the study. * Any condition judged by the investigators to limit compliance or increase study risk (e.g., psychiatric disorders, inability to adhere to fasting requirements).
Where it's running
-
Av. de Sánchez Pizjuán, s/n, 41009 Sevilla Facultad de Medicina . Universidad de Sevilla
Seville, Sevilla, Spain Recruiting
Study contacts
- Study coordinator: Sergio Montserrat-de la Paz, Full Professor
- Email: delapaz@us.es
- Phone: +34 605383541
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Rutazyme lemon fermented capsules for metabolic health in adults with obesity
This will test whether taking a Rutazyme lemon fermented capsule each night can help improve metabolic health in adults with obesity.
-
Brain PET scan with [18F]NIDF to see tau protein in Alzheimer’s and other tau-related diseases
We are testing whether a new PET tracer called [18F]NIDF can safely show tau protein in the brains of healthy adults and people with Alzheimer’s disease or other tauopathies.
-
Pre-screening to identify adults who may be eligible for future metabolic and mental health opportunities.
This prescreening will see if adults with metabolic conditions or mental health disorders qualify for upcoming clinical opportunities by collecting health history, basic tests, and a doctor interview.
-
Investigating inflammation's role in heart disease and diabetes
This study is testing how inflammation affects heart disease and diabetes in people who are healthy compared to those who are severely obese, to see if it can help identify who might benefit from new treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.